Free Trial

Procter & Gamble (NYSE:PG) Shares Up 0.2% - Time to Buy?

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report) was up 0.2% during trading on Thursday . The company traded as high as $171.82 and last traded at $170.97. Approximately 828,397 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 6,684,733 shares. The stock had previously closed at $170.63.

Analyst Ratings Changes

Several research firms recently issued reports on PG. DZ Bank upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price objective for the company in a research report on Thursday, August 29th. Wolfe Research upgraded shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a research report on Thursday, September 19th. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 price objective for the company. Finally, Evercore ISI raised their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $180.45.

Get Our Latest Research Report on PG

Procter & Gamble Trading Up 0.1 %

The company's 50 day moving average price is $170.68 and its 200 day moving average price is $169.50. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market cap of $402.38 billion, a PE ratio of 29.48, a price-to-earnings-growth ratio of 3.68 and a beta of 0.44.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the firm posted $1.83 earnings per share. The business's revenue for the quarter was down .6% compared to the same quarter last year. As a group, analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. Procter & Gamble's dividend payout ratio is currently 69.31%.

Insider Buying and Selling

In other news, CEO Jon R. Moeller sold 7,007 shares of the business's stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 2.54 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 83,080 shares of company stock worth $14,629,038 over the last 90 days. 0.18% of the stock is owned by insiders.

Institutional Trading of Procter & Gamble

Institutional investors have recently modified their holdings of the stock. International Assets Investment Management LLC increased its holdings in shares of Procter & Gamble by 19,030.8% in the 3rd quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company's stock valued at $639,730,000 after acquiring an additional 3,674,286 shares during the period. Wulff Hansen & CO. increased its holdings in shares of Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company's stock valued at $606,230,000 after acquiring an additional 3,653,477 shares during the period. Geode Capital Management LLC increased its holdings in shares of Procter & Gamble by 7.0% in the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock valued at $9,538,327,000 after acquiring an additional 3,619,466 shares during the period. Franklin Resources Inc. increased its holdings in shares of Procter & Gamble by 10.2% in the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company's stock valued at $3,290,573,000 after acquiring an additional 1,760,214 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at $301,950,000. Hedge funds and other institutional investors own 65.77% of the company's stock.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines